Aquestive Therapeutics Exceeds Top End of Guidance Range for Preliminary Unaudited Full Year 2019 Total Revenues and Provides Initial Full Year 2020 Guidance
Stock Information for Aquestive Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.